CAS No – 1396640-59-7

Status – Pre-Validation

Product Description

Rezafungin is an echinocandin antifungal agent approved for treating candidemia and invasive candidiasis in adults. It works by inhibiting the fungal-specific enzyme 1,3-beta-D-glucan synthase, which is crucial for fungal cell wall synthesis, leading to fungal cell death. Rezafungin is administered intravenously and is unique for its once-weekly dosing.